Prevalence and Risk Factors for Vascular Calcification in Chinese Patients Receiving Dialysis: Baseline Results from a Prospective Cohort Study
Zhi-Hong Liu,Xue-Qing Yu,Jun-Wei Yang,Ai-Li Jiang,Bi-Cheng Liu,Chang-Ying Xing,Ji-Zhuang Lou,Mei Wang,Hong Cheng,Jun Liu,Jun-Zhou Fu,Ai-Hua Zhang,Miao Zhang,Qiao-Ling Zhou,Chen Yu,Rong Wang,Li Wang,Yu-Qing Chen,Tian-Jun Guan,Ai Peng,Nan Chen,Chuan-Ming Hao,Xu-Yang Chen
DOI: https://doi.org/10.1080/03007995.2018.1467886
2018-01-01
Current Medical Research and Opinion
Abstract:Objective: With limited data available on calcification prevalence in chronic kidney disease (CKD) patients on dialysis, the China Dialysis Calcification Study (CDCS) determined the prevalence of vascular/valvular calcification (VC) and association of risk factors in Chinese patients with prevalent hemodialysis (HD) or peritoneal dialysis (PD). Methods: CKD patients undergoing HD/PD for >= 6 months were enrolled. Prevalence data for calcification and medical history were documented at baseline. Coronary artery calcification (CAC) was assessed by electron beam or multi-slice computed tomography (EBCT/MSCT), abdominal aortic calcification (AAC) by lateral lumbar radiography, and cardiac valvular calcification (ValvC) by echocardiography. Serum phosphorus, calcium, intact parathyroid hormone (iPTH), and 25-hydroxyvitamin D and FGF-23 were evaluated. A logistic regression model was used to evaluate the association between risk factors and VC. Results: Of 1,497 patients, 1,493 (78.3% HD, 21.7% PD) had >= 1 baseline calcification image (final analysis cohort, FAC) and 1,423 (78.8% HD, 21.2% PD) had baseline calcification data complete (BCDC). Prevalence of VC was 77.4% in FAC (80.8% HD, 65.1% PD, p<.001) and 77.5% in BCDC (80.7% HD, 65.8% PD). The proportion of BCDC patients with single-site calcification were 20% for CAC, 4.3% for AAC, and 4.3% for cardiac valvular calcification (ValvC), respectively. Double site calcifications were 23.4% for CAC and AAC, 6.5% for CAC and ValvC, and 1.1% for AAC and ValvC, respectively. In total, 17.9% patients had calcification at all three sites. Conclusions: High prevalence of total VC in Chinese CKD patients will supplement current knowledge, which is mostly limited, contributing in creating awareness and optimizing VC management.